Mathematical virology, virus evolution, infectivity, vaccine breakthrough and antibody resistance

 

*     Third party YouTube about our work on SARS-CoV-2

*     SARS-CoV-2 Mutation Tracker

*     SARS-CoV-2 Mutation Analyzer

*     SARS-CoV-2 RBD Mutations in the US.

*     Emerging dominant SARS-CoV-2 variants, Journal of Chemical Information and Modeling, accepted (2022).

*     Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants, Computers in Biology and Medicine, 151, 106262, (2022).

*     Omicron BA.2 (B.1.1.529.2): high potential to becoming the next dominating variant, The Journal of Physical Chemistry Letters, 13, 3840-3849 (2022).

*     Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance, Journal of Chemical Information and Modeling, 62 (2), 412-422 (2022).

*     Artificial intelligence design of mutation-proof COVID-19 antibody therapies, Communications in Information and Systems, accepted, (2022).

*     Review of the mechanisms of SARS-CoV-2 evolution and transmission, Chemical Science, (2021).

*     Emerging vaccine-breakthrough SARS-CoV-2 variants, ACS Infectious Diseases, 8, 3, 546556 (2022).

*     Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2, Chemical Reviews, Chemical Review, 122, 13, 112871136 (2022).

*     Mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America, The Journal of Physical Chemistry Letters, 12, 11850-11857 (2021).

*     Perspective of SARS-CoV-2 main protease inhibitors, Journal of Medicinal Chemistry, 64, 16922-16955 (2021).

*     Revealing the threat of emerging SARS-CoV-2 mutations to antibody therapies, Journal of Molecular Biology, 433, 167155 (2021).

*     Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, South Africa, and other COVID-19-devastated countries, Genomics, 11, 2158-2170 (2021).

*     UMAP-assisted K-means clustering of large-scale SARS-CoV-2 mutation datasets, Computers in Biology and Medicine, 131, 104264 (2021).

*     Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies, Chemical Science, 12, 6929 - 6948 (2021).

*     SARS-CoV-2 becoming more infectious as revealed by algebraic topology and deep learning, Communications in Information and Systems, 21(1), 31-36 (2021).

*     Host immune response driving SARS-CoV-2 evolution, Viruses, 12, 1095 (2020).

*     Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants, Communications Biology, 4, 228 (2021).

*     Decoding asymptomatic COVID-19 infection and transmission, The Journal of Physical Chemistry Letters, 11, 10007-10015 (2020).

*     Review of COVID-19 antibody therapies, Annual Review of Biophysics, 50, 1-30, (2021).

*     Mutations strengthened SARS-CoV-2 infectivity, Journal of Molecular Biology, 432, 5212-5226 (2020).

*     Mutations on COVID-19 diagnostic targets, Genomics, 112, 5204-5213 (2020).

*     Repositioning of 8565 existing drugs for COVID-19, The Journal of Physical Chemistry Letters, 11, 13, 53735382 (2020).

*     Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 92 crystal structures, Chemical Science, 11, 12036 - 12046 (2020).

*     Decoding SARS-CoV-2 transmission, evolution and ramification on COVID-19 diagnosis, vaccine, and medicine, Journal of Chemical Information and Modeling, 60, 5853-5865 (2020).

*     Potentially highly potent drugs for 2019-nCoV

*     Machine intelligence design of 2019-nCoV drugs